From brain to blood: Alternative splicing evidence for the cholinergic basis of mammalian stress responses

Annals of the New York Academy of Sciences

Volumn 1018, Issue , 2004, Pages 85-98

  Pick, Marjorie ^a,b   Flores Flores, Cesar ^a,c   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Acetylcholinesterase; Alternative splicing; Blood; Brain; Inflammation; Stress

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENE PRODUCT; INSECTICIDE; MESSENGER RNA; NEUROTRANSMITTER; PHYSOSTIGMINE;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; BLOOD CELL; BRAIN; BRAIN NERVE CELL; CATALYSIS; CATALYST; CELL COMPOSITION; CHOLINERGIC SYSTEM; CONFERENCE PAPER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC SYSTEM; HUMAN; INFLAMMATION; MAMMAL; MEGAKARYOPOIESIS; MOLECULAR PROBE; NONHUMAN; REGULATORY MECHANISM; STRESS;

ANIMALIA; MAMMALIA;

EID: 3242678754     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1296.010     Document Type: Conference Paper

References (79)

1. IMPERATO, A., S. PUGLISI-ALLEGRA, P. CASOLINI, et al. 1991. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538: 111-117.
2. XIE, J. & D.P. MCCOBB. 1998. Control of alternative splicing of potassium channels by stress hormones. Science 280: 443-446.
3. KAUFER, D., A. FRIEDMAN, S. SEIDMAN, et al. 1998. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393: 373-377.
4. KAUFER, D. & H. SOREQ. 1999. Tracking cholinergjc pathways from psychological and chemical stressors to variable neurodegeneration paradigms. Curr. Opin. Neurol. 12: 739-743.
5. SOREQ, H. & S. SEIDMAN. 2001. Acetylcholinesterase: new roles for an old actor. Nat. Rev. Neurosci. 2: 294-302.
6. BEHRA, M., X. COUSIN, C. BERTRAND, et al. 2002. Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat. Neurosci. 5: 111-118.
7. BEN AZIZ-ALOYA, R., S. SEIDMAN, R. TIMBERG, et al. 1993. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. Proc. Natl. Acad. Sci. USA 90: 2471-2475.
8. SOREQ, H., R. BEN-AZIZ, C.A. PRODY, et al. 1990. Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure. Proc. Natl. Acad. Sci. USA 87: 9688-9692.
9. GRISARU, D., M. STERNFELD, A. ELDOR, et al. 1999. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264: 672-686.
10. MASSOULIE, J. 2002. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11: 130-143.
11. SHAPIRA, M., I. TUR-KASPA, L. BOSGRAAF, et al. 2000. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9: 1273-1281.
12. LI, Y., S. CAMP & P. TAYLOR. 1993. Tissue-specific expression and alternative mRNA processing of the mammalian acetylcholinesterase gene. J. Biol. Chem. 268: 5790-5797.
13. KARPEL, R., R. BEN AZIZ-ALOYA, M. STERNFELD, et al. 1994. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. Exp. Cell Res. 210: 268-277.
14. LEV-LEHMAN, E., T. EVRON, R.S. BROIDE, et al. 2000. Synaptogenesis and myopathy under acetylcholinesterase overexpression. J. Mol. Neurosci. 14: 93-105.
15. ERB, C., J. TROOST, S. KOPF, et al. 2001. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77: 638-646.
16. COHEN, O., C. ERB, D. GINZBERG, et al. 2002. Neuronal overexpression of "readthrough" acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol. Psychiatry 7: 874-885.
17. SHOHAMI, E., D. KAUFER, Y. CHEN, et al. 2000. Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78: 228-236.
18. BIRIKH, K.R., E.H. SKLAN, S. SHOHAM, et al. 2003. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior. Proc. Natl. Acad. Sci. USA 100: 283-288.
19. MESHORER, E., C. ERB, R. GAZIT, et al. 2002. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295: 508-512.
20. PERRIER, A.L., J. MASSOULIE & E. KREJCI. 2002. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33: 275-285.
21. OHNO, K., J.M. BRENGMAN, K.J. FELICE, et al. 1999. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A→G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing? Am. J. Hum. Genet. 65: 635-644.
22. SEIDMAN, S., M. STERNFELD, R. BEN AZIZ-ALOYA, et al. 1995. Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3′-terminal exons. Mol. Cell Biol. 15: 2993-3002.
23. GRIFMAN, M., N. GALYAM, S. SEIDMAN, et al. 1998. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc. Natl. Acad. Sci. USA 95: 13935-13940.
24. BEERI, R., N. LE NOVERE, R. MERVIS, et al. 1997. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69: 2441-2451.
25. STERNFELD, M., S. SHOHAM, O. KLEIN, et al. 2000. Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA 97: 8647-8652.
26. PERRY, C., E.H. SKLAN, K. BIRIKH, et al. 2002. Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21: 8428-8441.
27. SHORS, T.J., G. MIESEGAES, A. BEYLIN, et al. 2001. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410: 372-376.
28. ANDRES, C., R. BEERI, A. FRIEDMAN, et al. 1997. Acetylcholinesterase- transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. USA 94: 8173-8178.
29. MOR, I., D. GRISARU, L. TITELBAUM, et al. 2001. Modified testicular expression of stress-associated "readthrough" acetylcholinesterase predicts male infertility. Faseb J. 15: 2039-2041.
30. BEERI, R., C. ANDRES, E. LEV-LEHMAN, et al. 1995. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5: 1063-1071.
31. SVEDBERG, M.M., A.L. SVENSSON, M. JOHNSON, et al. 2002. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. J. Mol. Neurosci. 18: 211-222.
32. FARCHI, N., H. SOREQ & B. HOCHNER. 2003. Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology. J. Physiol. 546: 165-173.
33. STERNFELD, M., J.D. PATRICK & H. SOREQ. 1998. Position effect variegations and brain-specific silencing in transgenic mice overexpressing human acetylcholinesterase variants. J. Physiol. Paris 92: 249-255.
34. JANDI, J. 1987. Blood. Little, Brown. Boston.
35. OGAWA, M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81: 2844-2853.
36. MIAN, R., G. SHELTON-RAYNER, B. HARKIN, et al. 2003. Observing a fictitious stressful event: haematological changes, including circulating leukocyte activation. Stress 6: 41-47.
37. LIM, F. T., L. VAN WINSEN, R. WILLEMZE, et al. 1994. Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord blood. Blood Cells 20: 547-558; discussion 558-559.
38. AVRAHAM, H. 1993. Regulation of megakaryocytopoiesis. Stem Cells 11: 499-510.
39. CARDIER, J., D. FOSTER, S. LOK, et al. 1996. Megakaryocytopoiesis in vitro: from the stem cells' perspective. Stem Cells 14: 163-171.
40. PAOLETTI, F., A. MOCALI & A.M. VANNUCCHI. 1992. Acetylcholinesterase in murine erythroleukemia (Friend) cells: evidence for megakaryocyte-like expression and potential growth-regulatory role of enzyme activity. Blood 79: 2873-2879.
41. BURSTEIN, S.A., J.W. ADAMSON & L.A. HARKER. 1980. Megakaryocytopoiesis in culture: modulation by cholinergic mechanisms. J. Cell Physiol. 54: 201-208.
42. LEV-LEHMAN, E., V. DEUTSCH, A. ELDOR, et al. 1997. Immature human megakaryocytes produce nuclear-associated acetylcholinesterase. Blood 89: 3644-3653.
43. TOPILKO, A. & B. CAILLOU. 1985. Acetylcholinesterase in human thymus cells. Blood 66: 891-895.
44. KAWASHIMA, K. & T. FUJII. 2000. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86: 29-48.
45. GRISARU, D., V. DEUTSCH, M. SHAPIRA, et al. 2001. ARP, a peptide derived from the stress-associated acetylcholinesterase variant has hematopoietic growth promoting activities. Mol. Med. 7: 93-105.
46. EHRLICH, G., E. VIEGAS PEQUIGNOT, D. GINZBERG, et al. 1992. Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries. Genomics 13: 1192-1197.
47. PERRY, C., A. ELDOR & H. SOREQ. 2002. Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Leuk. Res. 26: 221-228.
48. BROWN, L.M., A. BLAIR, R. GIBSON, et al. 1990. Pesticide exposure and other agricultural risk factors for leukemia among man in Iowa and Minnesota. Cancer Res. 50: 6585-6591.
49. ZAKUT, H., Y. LAPIDOT-LIFSON, R. BEERI, et al. 1992. In vivo gene amplification in non-cancerous cells: cholinesterase genes and oncogenes amplify in thrombocytopenia associated with lupus erythematosus. Mutat. Res. 276: 275-284.
50. DEUTSCH, V., M. PICK, C. PERRY, et al. 2002. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Exp. Hematol. 30: 1153-1161.
51. COHEN, O., A. REICHENBERG, C. PERRY, et al. 2003. Endotoxin-induced charges in human working and declarative memory are associated with C-terminal cleavage of plasma "readthrough" acetylcholinesterase. J. Mol. Neurosci. In press.
52. LORENZL, S., D.S. ALBERS, N. RELKIN, et al. 2003. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem. Int. 43: 191-196.
53. BOROVIKOVA, L.V., S. IVANOVA, M. ZHANG, et al. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
54. TRACEY, K.J. 2002. The inflammatory reflex. Nature 420: 853-859.
55. TOFT, P., H.S. HELBO-HANSEN, E. TONNESEN, et al. 1994. Redistribution of granulocytes during adrenaline infusion and following administration of cortisol in healthy volunteers. Acta Anaesthesiol. Scand. 38: 254-258.
56. BLACK, P.H. 2002. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav. Immun. 16: 622-653.
57. MILLER, G.E., S. COHEN & A.K. RITCHEY. 2002. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid- resistance model. Health Psychol. 21: 531-541.
58. DEBILI, N., L. COULOMBEL, L. CROISILLE, et al. 1996. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88: 1283-1296.
59. JACKSON, C.W. 1973. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42: 413-421.
60. PAULUS, J.M., J.F. DESCHAMPS, M. PRENANT, et al. 1980. Kinetics of platelets, megakaryocytes and their precursors: what to measure? Blood Cells 6: 215-228.
61. BURSTEIN, S.A. & L.A. HARKER. 1983. Control of platelet production. Clin. Hematol. 12: 3-27.
62. SOREQ, H., D. PATINKIN, E. LEV-LEHMAN, et al. 1994. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. Proc. Natl. Acad. Sci. USA 91: 7907-7911.
63. LEV-LEHMAN, E., D. GINZBERG, G. HORNREICH, et al. 1994. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. Gene Ther. 1: 127-135.
64. FLORES-FLORES, C., A. NISSIM, S. SHOCHAT, et al. 2002. Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library. J. Neural. Transm. 62(Suppl.): 165-179.
65. PICK, M., C. FLORES-FLORES, D. GRISARU, et al. 2004. Blood cells-specific acetylcholinesterase splice variations under changing stimuli. Int. J. Dev. Neurosci. In press.
66. WEXLER, B., A. DOLGIN & E. TRYCZYNSK. 1957. Effects of a bacterial polysaccharide (Piromen) on the pituitary-adrenal axis: adrenal ascorbic acid, cholesterol and histologic alterations. Endocrinology 61: 300-308.
67. BLALOCK, J.E. 1989. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 69: 1-32.
68. BREDER, C.D., C.A. DINARELLO & C.B. SAPER. 1988. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240: 321-324.
69. BREDER, C.D., C. HAZUKA, T. GHAYUR, et al. 1994. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. USA 91: 11393-11397.
70. KLEGERIS, A., T.C. BUDD & S.A. GREENFIELD. 1994. Acetylcholinesterase activation of peritoneal macrophages is independent of catalytic activity. Cell Mol. Neurobiol. 14: 89-98.
71. RICHARDSON, J.D. & M.R. VASKO. 2002. Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Ther. 302: 839-845.
72. NORDBERG, A., A. ADEM, J. HARDY, et al. 1988. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci. Lett. 86: 317-321.
73. DEKOSKY, S.T. & S.W. SCHEFF. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27: 457-464.
74. DAVIES, P. & A.J. MALONEY. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease [letter]. Lancet 2: 1403.
75. COYLE, J.T., D.L. PRICE & M.R. DELONG. 1983. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184-1190.
76. MRAK, R.E. & W.S. GRIFFIN. 2001. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 22: 903-908.
77. LI, Y., L. LIU, J. KANG, et al. 2000. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20: 149-155.
78. ABRAMSON, N. & B. MELTON. 2000. Leukocytosis: basics of clinical assessment. Am. Fam. Physician. 62: 2053-2060.
79. PAYNE, K.J. & G.M. CROOKS. 2002. Human hematopoietic lineage commitment. Immunol. Rev. 187: 48-64.